Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers (scientific article)

HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1.

Q24541580

Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer

Q24550887

Somatic mutations affect key pathways in lung adenocarcinoma

Q24648102

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

Q24651026

Global cancer statistics, 2002

Q27860562

The consensus coding sequences of human breast and colorectal cancers

Q27861035

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines

Q28202433

Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer

Q28204269

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers

Q28214439

Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer

Q28217003

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

Q28248276

Lung cancer in never smokers: a review

Q28287500

The epigenomics of cancer

Q28289975

Aberrant methylation of Reprimo in human malignancies

Q28306530

Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis

Q28472991

Lung cancer in never smokers--a different disease

Q29615414

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

Q33300134

The new World Health Organization classification of lung tumours

Q34112802

Association of meiotic arrest with lack of BOULE protein expression in infertile men.

Q34311879

Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers

Q34351025

Association of three isoforms of the meiotic BOULE gene with spermatogenic failure in infertile men.

Q34582805

Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients

Q35060286

Gene-promoter hypermethylation as a biomarker in lung cancer

Q35877182

Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation

Q36790428

Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells

Q39923075

Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.

Q40002585

Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors

Q40213076

Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer.

Q40536844

Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.

Q44542352

Aberrant methylation of Reprimo in lung cancer

Q45267063

Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers

Q47885434

Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Q51657031

Lung cancer death rates in lifelong nonsmokers.

Q51804779

Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.

Q53346861

CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes.

Q53466648

Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never Smokers

Q57918851

Lung cancer, smoke exposure, and sex

Q79750593

Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer

Q81463886

Identification of 20 genes aberrantly methylated in human breast cancers

Q81629206

Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort

Q82843914

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

adenocarcinoma

Q356033

P304

page(s)

1132-8

P577

publication date

2009-07-01

P1433

published in

Carcinogenesis

Q326022

P1476

title

Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers

P478

volume

Reverse relations

cites work (P2860)

Q36803539	A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
Q64983051	Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines.
Q37214386	Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model
Q35233697	Ambient PM exposure and DNA methylation in tumor suppressor genes: a cross-sectional study
Q36340108	Biomarkers and the genetics of early neoplastic lesions
Q37633163	CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
Q34103461	Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis
Q39609163	Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model
Q28304465	Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer
Q37642982	DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
Q38018995	DNA methylation biomarkers in cancer: progress towards clinical implementation
Q39418597	DNA methylation of the CYP1A1 enhancer is associated with smoking-induced genetic alterations in human lung.
Q64387061	DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells
Q36355560	Defining a gene promoter methylation signature in sputum for lung cancer risk assessment
Q35880987	Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer
Q39373653	Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine).
Q26996766	Epigenetics of lung cancer
Q64120284	Exposure to polycyclic aromatic hydrocarbons derived from vehicle exhaust gas induces premature senescence in mouse lung fibroblast cells
Q34044005	GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer
Q39366723	Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.
Q37855515	Genetic and epigenetic changes in lung carcinoma and their clinical implications
Q45906493	Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.
Q42270103	Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer
Q33947935	Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers
Q54381660	Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
Q34216446	HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
Q37485675	Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion
Q36464478	Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming
Q35160337	Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients
Q36189699	Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma
Q36182205	Methylated Genes in Sputum Among Older Smokers With Asthma.
Q39064248	MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells.
Q52974103	Oncogenic Role of BOLL in Colorectal Cancer.
Q35761818	Particulate matter Air Pollution induces hypermethylation of the p16 promoter Via a mitochondrial ROS-JNK-DNMT1 pathway
Q34134446	Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis
Q39007185	Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer
Q35840419	SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
Q37432727	Smoking and microRNA dysregulation: a cancerous combination
Q57804585	Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer
Q38500320	Targeting of cancer stem cells by inhibitors of DNA and histone methylation.
Q34762265	The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas